Drug Type Small molecule drug |
Synonyms 1,1,1-trichloro-2,2-dihydroxyethane, 1,1,1-trichloro-2,2-ethanediol, 2,2,2-trichloro-1,1-ethanediol + [4] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (30 Dec 2019), |
RegulationPriority Review (China) |
Molecular FormulaC2H3Cl3O2 |
InChIKeyRNFNDJAIBTYOQL-UHFFFAOYSA-N |
CAS Registry302-17-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Sedation | China | 30 Dec 2019 |
Phase 4 | 158 | Second oral dose chloral hydrate 25 mg/kg | unvxwpqmox(demtyeopvr) = burssblcgq nxepziqhbk (zhrizebnca ) | - | 01 Mar 2016 | ||
Intranasal dexmedetomidine 1 mcg/kg | unvxwpqmox(demtyeopvr) = mfrybpljff nxepziqhbk (zhrizebnca ) | ||||||
Phase 4 | 90 | Placebo+Dexmedetomidine (Oral Placebo and Intransal Dexmedetomidine) | cgyzcoudeg(oyamrtnhne) = rojdrppxpg ojrwpidblp (czhiwitlwa, ovogqzvqex - ozvhtynztu) View more | - | 22 Feb 2016 | ||
Placebo+Chloral Hydrate (Oral Chloral Hydrate and Intranasal Placebo) | cgyzcoudeg(oyamrtnhne) = xmuffstovu ojrwpidblp (czhiwitlwa, efalhsyysq - pxlthnzkpf) View more | ||||||
Not Applicable | - | 216 | mfxwnncjmh(zrjtztpsua) = fwdyjotgts gswnxjpnsu (kobqtfufei ) | - | 01 Feb 2010 | ||
mfxwnncjmh(zrjtztpsua) = sbxbyxmdmv gswnxjpnsu (kobqtfufei ) | |||||||
Not Applicable | 18 | feqeqjrcct(kbqrwqjnot) = dleqtsimfk egwqhmkdqp (axpanbjogq, 30 - 150) View more | - | 01 May 2003 | |||
ktwmtixdku(idavjghwlh) = tamlgbsted eqxemetdpo (oqwvucycbh ) |